Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Diovan/Co-Diovan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Diovan/Co-Diovan was produced by Novartis.

Novartis knocks Pfizer off sales leader board

Novartis knocks Pfizer off sales leader board and a strong pipeline of drugs across multiple therapy areas, has helped it stave off major losses from the $6bn a year sales once coming from its blood pressure pill Diovan

Novartis' heart failure drug could get FDA nod in summer

Novartis' heart failure drug could get FDA nod in summer It has also been granted a priority review in Switzerland. LCZ696 is a follow-up to Novartis' big-selling angiotensin II receptor antagonist Diovan (valsartan) - combining the AIIRA with novel neprilysin

Novartis' Japanese subsidiary threatened with suspension

Novartis' Japanese subsidiary threatened with suspension Last year, prosecutors in Japan laid formal charges against Novartis in an ongoing investigation about the manipulation of clinical data, centring on studies of the company's blood pressure treatment Diovan

FDA panel votes against Actavis hypertension combo

FDA panel votes against Actavis hypertension combo Places a question mark over the combination of Bystolic and Diovan. ... Valsartan - an angiotensin II receptor blocker - was until recently marketed solely by Novartis as Diovan, becoming one of the world's biggest selling drugs with sales topping $4bn.

Milestone names chief medical officer

Milestone names chief medical officer His other big pharma experience includes roles at Daiichi-Sankyo, Novartis, and Bristol Myers Squibb, working on cardiovascular products including Efient, Diovan and Approvel.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics